Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.7 |